These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7335622)

  • 21. ['Cardiac ballet' with and without amiodarone].
    Balestra B; Hess T
    Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
    Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
    Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of the "long Q-T and peak-torsion syncope" syndrome caused by prenylamine].
    Aloisi B; Stuto A; Mossuti E; Brancati BM
    Minerva Cardioangiol; 1978 Oct; 26(10):687-92. PubMed ID: 750945
    [No Abstract]   [Full Text] [Related]  

  • 24. Torsades de pointes as a manifestation of mexiletine toxicity.
    Cocco G; Strozzi C; Chu D; Pansini R
    Am Heart J; 1980 Dec; 100(6 Pt 1):878-80. PubMed ID: 7446392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
    Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA
    Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
    Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Torsades de pointes and long QT syndromes.
    Janeira LF
    Am Fam Physician; 1995 Oct; 52(5):1447-53. PubMed ID: 7572567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overdrive pacing in quinidine syncope and other long QT-interval syndromes.
    DiSegni E; Klein HO; David D; Libhaber C; Kaplinsky E
    Arch Intern Med; 1980 Aug; 140(8):1036-40. PubMed ID: 7396607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An unusual cause of giddiness. Fig. 1: Complete heart block with prolonged QT interval. Fig. 2: Torsades de pointes.
    Ng KS; Choo MH
    Singapore Med J; 1993 Feb; 34(1):81-2, 92. PubMed ID: 8266138
    [No Abstract]   [Full Text] [Related]  

  • 33. [Torsade de Pointes and demand endocavitary pacemaker. A case report].
    Pardo J; Novoa O; González R
    Rev Med Chil; 1998 Dec; 126(12):1503-6. PubMed ID: 10349166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenylamine-induced ventricular arrhythmias and syncopal attacks with Q-T prolongation. Report of a case and comment on therapeutic use of lignocaine.
    Riccioni N; Bartolomei C; Soldani S
    Cardiology; 1980; 66(4):199-203. PubMed ID: 7448836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
    Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
    Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Torsades de pointes].
    Guize L; Iliou MC; Bayet G; Lavergne T; Le Heuzey JY
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):769-76. PubMed ID: 8267505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haloperidol-induced torsades de pointes.
    Kriwisky M; Perry GY; Tarchitsky D; Gutman Y; Kishon Y
    Chest; 1990 Aug; 98(2):482-4. PubMed ID: 2376181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
    Atkinson D; Dunne A; Parker M
    Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.